EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Scope & Guideline
Transforming insights into clinical practices.
Introduction
Aims and Scopes
- Clinical Research in Gastroenterology and Hepatology:
The journal publishes studies that investigate clinical outcomes, treatment efficacy, and disease management in gastroenterology and hepatology, emphasizing real-world applications and patient-centered care. - Innovative Diagnostic and Therapeutic Techniques:
Research on the development and evaluation of new diagnostic tools and therapeutic interventions, including endoscopic procedures and minimally invasive techniques, is a core focus area. - Epidemiological Studies and Public Health:
The journal features epidemiological research that explores the prevalence, risk factors, and public health implications of gastrointestinal and liver diseases, contributing to evidence-based healthcare policies. - Basic and Translational Research:
Studies that investigate the underlying mechanisms of gastrointestinal and liver diseases at the molecular and cellular levels, including pathophysiology and genetic factors, are highly valued. - Nutritional and Lifestyle Interventions:
The journal encourages research that examines the impact of diet, nutrition, and lifestyle modifications on gastrointestinal and liver health, reflecting the growing interest in holistic approaches to disease management. - Patient Quality of Life and Health Economics:
Research assessing the quality of life in patients with gastrointestinal and liver diseases, as well as cost-effectiveness analyses of treatments, is increasingly prominent in the journal.
Trending and Emerging
- Artificial Intelligence in Gastroenterology:
There is an increasing trend in the exploration of artificial intelligence and machine learning applications for improving diagnostic accuracy and treatment outcomes in gastroenterology, reflecting the digital transformation in healthcare. - Microbiome Research:
Studies investigating the role of the gut microbiome in gastrointestinal health and disease, including its impact on treatment responses and disease mechanisms, have gained significant attention in recent years. - Personalized Medicine and Targeted Therapies:
The focus on personalized medicine, especially in the context of inflammatory bowel disease and liver disorders, is trending, with research aimed at tailoring treatments based on individual patient profiles. - Integrative Approaches to Treatment:
There is a growing interest in integrative medicine, emphasizing the combination of conventional therapies with dietary, lifestyle, and complementary approaches to enhance patient outcomes. - Longitudinal Cohort Studies:
The trend of conducting long-term cohort studies to track disease progression and treatment efficacy over time is rising, providing valuable insights into chronic conditions such as hepatitis and inflammatory bowel disease.
Declining or Waning
- Traditional Pharmacological Approaches:
There has been a noticeable shift towards innovative therapies and personalized medicine, leading to a decreased focus on traditional pharmacological treatments and their efficacy in managing gastrointestinal diseases. - Single-Center Studies:
The prevalence of single-center studies has diminished as there is a growing emphasis on multicenter collaborations that provide broader data and enhance the generalizability of findings across diverse populations. - Non-Interventional Studies:
The journal has seen a decline in the publication of purely observational studies that do not contribute to direct clinical applications or advancements in treatment protocols. - Basic Science without Clinical Relevance:
Research that lacks direct applicability to clinical practice or does not address pressing clinical questions has become less favored, as the journal prioritizes studies with tangible impacts on patient care. - Outdated Techniques and Technologies:
As new diagnostic and therapeutic techniques emerge, studies focusing on outdated or less effective methods have decreased, reflecting the journal's commitment to advancing contemporary practices.
Similar Journals
Korean Journal of Gastroenterology
Uniting Experts for Enhanced Digestive Health SolutionsKorean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Connecting researchers and clinicians for better outcomes.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
Gastroenterologia y Hepatologia
Advancing knowledge in gastrointestinal and liver health.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Transforming Therapeutics in Gastroenterology and HepatologyALIMENTARY PHARMACOLOGY & THERAPEUTICS, published by Wiley, is a premier scholarly journal in the fields of gastroenterology, hepatology, and pharmacology. With an impressive impact factor and ranking in the top quartile (Q1) of its classifications, the journal is recognized for its rigorous peer-reviewed research and comprehensive reviews, aiming to advance the understanding of therapeutic interventions in gastrointestinal and liver diseases. Since its inception in 1987, it has become an essential resource for researchers, healthcare professionals, and students alike, fostering scientific dialogue and innovation. With a Scopus rank placing it in the 97th percentile for pharmacology and 96th for gastroenterology, it is dedicated to publishing the most significant and impactful findings in the field. ALIMENTARY PHARMACOLOGY & THERAPEUTICS thus plays a vital role in shaping the future of medical treatments and interventions in gastrointestinal health.
Gastroenterology Insights
Connecting Researchers to Shape Gastroenterology's FutureGastroenterology Insights is a premier open-access journal published by MDPI since 2009, focusing on essential research and developments within the fields of gastroenterology and hepatology. With a dedicated ISSN of 2036-7414 and E-ISSN 2036-7422, this journal serves as a vital platform for disseminating innovative studies and insights pertinent to gastrointestinal health, disorders, and treatment modalities. Based in Switzerland, Gastroenterology Insights boasts a significant academic presence, currently positioned in the Q3 quartile for both gastroenterology and hepatology categories as of 2023, reflecting its impactful contributions to the disciplines. With Scopus rankings placing it at the 94th and 48th positions in gastroenterology and hepatology respectively, the journal is committed to advancing knowledge and fostering collaboration among researchers, professionals, and students alike. By providing an open-access model, it ensures that high-quality research is accessible globally, thereby enhancing the reach and impact of crucial findings in the science of digestive health. Researchers looking to publish cutting-edge work will find Gastroenterology Insights a valuable resource for both sharing and acquiring knowledge.
ZEITSCHRIFT FUR GASTROENTEROLOGIE
Pioneering Knowledge in Gastroenterology and BeyondZEITSCHRIFT FUR GASTROENTEROLOGIE, published by GEORG THIEME VERLAG KG, stands as a notable journal in the field of gastroenterology since its inception in 1971. With an ISSN of 0044-2771 and an E-ISSN of 1439-7803, this journal focuses on advancing knowledge and research in gastrointestinal health. Operating from Germany, its contributions span various aspects of gastroenterology, providing a platform for both established and emerging scholars to share their findings. As of 2023, ZEITSCHRIFT FUR GASTROENTEROLOGIE is ranked in the Q3 quartile in Gastroenterology and Q4 in Medicine (miscellaneous), reflecting its critical yet developing role in the academic community. Despite its current Scopus rank of #117 out of 167 in the gastroenterology category, the journal aims to foster innovative research and discussions vital for tackling contemporary challenges in gastrointestinal medicine. While it does not offer open access, the journal's extensive archival rigor ensures that pertinent studies remain accessible to professionals and academicians seeking to deepen their understanding and engage with evolving clinical practices.
Cellular and Molecular Gastroenterology and Hepatology
Transforming the landscape of gastroenterology and hepatology.Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.
Journal of Gastrointestinal and Liver Diseases
Advancing Knowledge in Gastrointestinal and Liver HealthThe Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.
With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.
Minerva Gastroenterology
Driving Progress in Gastroenterology and BeyondMinerva Gastroenterology, published by EDIZIONI MINERVA MEDICA, is a notable academic journal dedicated to advancing the field of gastroenterology and related disciplines. With an ISSN of 2724-5985 and an E-ISSN of 2724-5365, this journal gathers innovative research from diverse areas including internal medicine, endocrinology, and metabolism. Though characterized by its open-access policies, Minerva Gastroenterology aims to provide a platform for high-quality scholarly articles with an emphasis on critical reviews, clinical studies, and translational research. Since its inception in 2021, the journal has managed to secure a reputation reflected in its Q3 rank across multiple categories in 2023, as well as its standing in Scopus rankings, positioning it in the 45th to 47th percentile among renowned medical journals. Situated in Turin, Italy, it fosters collaboration and knowledge-sharing among researchers and practitioners, making it an essential resource for those seeking to deepen their understanding of gastroenterological conditions and enhance clinical practices.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Advancing Digestive Health Through Rigorous ResearchSCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.